UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 309

Sortiert nach

The development of an HIV-specific complexity rating scale

International journal of STD & AIDS, 2019-11, Vol.30 (13), p.1265-1274

2019

Volltextzugriff (PDF)

Camostat attenuates airway epithelial sodium channel function in vivo through the inhibition of a channel-activating protease

The Journal of pharmacology and experimental therapeutics, 2009-05, Vol.329 (2), p.764

2009

Volltextzugriff (PDF)

NVP‐QBE170: an inhaled blocker of the epithelial sodium channel with a reduced potential to induce hyperkalaemia

British journal of pharmacology, 2015-06, Vol.172 (11), p.2814-2826

2015

Volltextzugriff (PDF)

The guinea‐pig tracheal potential difference as an in vivo model for the study of epithelial sodium channel function in the airways

British journal of pharmacology, 2008-12, Vol.155 (7), p.1025-1033

2008

Volltextzugriff (PDF)

WS05.04 SPL84 efficient and durable effect, restoring 3849 +10 kb C-to-T mutated CFTR, when treated through the apical side of primary HBE cells

Journal of cystic fibrosis, 2024-06, Vol.23, p.S10-S10

2024

Volltextzugriff (PDF)

244 Cystic Fibrosis Foundation Therapeutics Lab: Biorepository expansion to represent a broad range of cystic fibrosis patients

Journal of cystic fibrosis, 2023-10, Vol.22, p.S124-S125

2023

Volltextzugriff (PDF)

305 Comparing functional responses of nonsense CFTR variants to modulators in human primary enteric monolayer, human bronchial epithelial, and 16hBEge cell cultures

Journal of cystic fibrosis, 2023-10, Vol.22, p.S153-S154

2023

Volltextzugriff (PDF)

307 Development of a robust protocol for functional assessment of CFTR in human primary enteric monolayer cultures grown on permeable filter supports

Journal of cystic fibrosis, 2023-10, Vol.22, p.S154-S155

2023

Volltextzugriff (PDF)

631 Comparing F508del cystic fibrosis transmembrane conductance regulator modulator responses in human primary enteric monolayer and human bronchial epithelial cultures

Journal of cystic fibrosis, 2022-10, Vol.21, p.S347-S347

2022

Volltextzugriff (PDF)

273 Screening the Calibr ReFRAME drug-repurposing library for efficient functional restoration of native CFTR nonsense variants

Journal of cystic fibrosis, 2023-10, Vol.22, p.S138-S138

2023

Volltextzugriff (PDF)

258 Standardization and utilization of human induced pluripotent stem cells for in vitro disease modeling of cystic fibrosis

Journal of cystic fibrosis, 2023-10, Vol.22, p.S130-S131

2023

Volltextzugriff (PDF)

634 Generation of a cystic fibrosis transmembrane conductance regulator R1162X “TAG” model and comparison of readthrough to the naturally occurring R1162X “TGA”

Journal of cystic fibrosis, 2022-10, Vol.21, p.S349-S349

2022

Volltextzugriff (PDF)

641 Building toward the future: The Cystic Fibrosis Foundation Therapeutics Lab as an expanding repository of primary cells with rare genotypes for cystic fibrosis research

Journal of cystic fibrosis, 2022-10, Vol.21, p.S352-S352

2022

Volltextzugriff (PDF)

257 Evaluating genetic components to move toward a highly effective CFTR super exon

Journal of cystic fibrosis, 2023-10, Vol.22, p.S130-S130

2023

Volltextzugriff (PDF)

328 Cystic Fibrosis Foundation Therapeutics Lab: Omics data repository from cystic fibrosis–relevant in vitro cell models

Journal of cystic fibrosis, 2023-10, Vol.22, p.S164-S164

2023

Volltextzugriff (PDF)

614 Sensitized high-throughput screening for translational readthrough promoters in the context of the native cystic fibrosis transmembrane conductance regulator R1162X gene

Journal of cystic fibrosis, 2022-10, Vol.21, p.S340-S340

2022

Volltextzugriff (PDF)

663 Modulation of cystic fibrosis transmembrane conductance regulator intron 22 alternative polyadenylation use may have therapeutic potential for the treatment of certain 3′ cystic fibrosis transmembrane conductance regulator premature termination codon variants

Journal of cystic fibrosis, 2022-10, Vol.21, p.S363-S363

2022

Volltextzugriff (PDF)

WS16.03 LUNAR-CF: an mRNA replacement approach for cystic fibrosis lung disease

Journal of cystic fibrosis, 2022-06, Vol.21, p.S31

2022

Volltextzugriff (PDF)

672: Development of a highly sensitive PTC readthrough assay in the context of the full CFTR gene

Journal of cystic fibrosis, 2021-11, Vol.20, p.S319

2021

Volltextzugriff (PDF)

591: A novel high-throughput screening assay for PTC readthrough modulators relies on the native CFTR gene: Profiling of known compounds

Journal of cystic fibrosis, 2021-11, Vol.20, p.S280-S281

2021

Volltextzugriff (PDF)

P13.12 Hiv sensitisation health care worker training in vanuatu

Sexually transmitted infections, 2015-09, Vol.91 (Suppl 2), p.A197-A197

2015

Volltextzugriff (PDF)

584: Delivery of SP-101 restores CFTR function in human CF airway epithelial cultures and drives hCFTRΔR transgene expression in the airways of ferrets

Journal of cystic fibrosis, 2021-11, Vol.20, p.S278

2021

Volltextzugriff (PDF)

675: Directed differentiation of iPS cells to an airway epithelial tissue model of CF suitable for transepithelial electrophysiology

Journal of cystic fibrosis, 2021-11, Vol.20, p.S320

2021

Volltextzugriff (PDF)

549: LUNAR-CF: A novel mRNA therapeutic approach to correct the root cause of cystic fibrosis lung disease

Journal of cystic fibrosis, 2021-11, Vol.20, p.S259

2021

Volltextzugriff (PDF)

638: Demonstration of pharmacologic N1303 K CFTR rescue in heterologous and human tissue-based model systems

Journal of cystic fibrosis, 2021-11, Vol.20, p.S303

2021

Volltextzugriff (PDF)

1 – 25 von 309

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(286)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(306)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

Science & Technology
(204)
Technology
(91)
Life Sciences & Biomedicine
(90)
Computer Science
(88)
Engineering
(88)
Engineering, Electrical & Electronic
(88)
Computer Science, Theory & Methods
(87)
Humans
(43)
Biological And Medical Sciences
(34)
Male
(34)
Animals
(31)
Female
(30)
Fundamental And Applied Biological Sciences. Psychology
(26)
Physical Sciences
(25)
Microbiology
(20)
Middle Aged
(19)
Adult
(18)
Chemistry
(18)
Aged
(17)
Educational Institutions
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The development of an HIV-specific complexity rating scale

Camostat attenuates airway epithelial sodium channel function in vivo through the inhibition of a channel-activating protease

NVP‐QBE170: an inhaled blocker of the epithelial sodium channel with a reduced potential to induce hyperkalaemia

The guinea‐pig tracheal potential difference as an in vivo model for the study of epithelial sodium channel function in the airways

WS05.04 SPL84 efficient and durable effect, restoring 3849 +10 kb C-to-T mutated CFTR, when treated through the apical side of primary HBE cells

244 Cystic Fibrosis Foundation Therapeutics Lab: Biorepository expansion to represent a broad range of cystic fibrosis patients

305 Comparing functional responses of nonsense CFTR variants to modulators in human primary enteric monolayer, human bronchial epithelial, and 16hBEge cell cultures

307 Development of a robust protocol for functional assessment of CFTR in human primary enteric monolayer cultures grown on permeable filter supports

631 Comparing F508del cystic fibrosis transmembrane conductance regulator modulator responses in human primary enteric monolayer and human bronchial epithelial cultures

273 Screening the Calibr ReFRAME drug-repurposing library for efficient functional restoration of native CFTR nonsense variants

258 Standardization and utilization of human induced pluripotent stem cells for in vitro disease modeling of cystic fibrosis

634 Generation of a cystic fibrosis transmembrane conductance regulator R1162X “TAG” model and comparison of readthrough to the naturally occurring R1162X “TGA”

641 Building toward the future: The Cystic Fibrosis Foundation Therapeutics Lab as an expanding repository of primary cells with rare genotypes for cystic fibrosis research

257 Evaluating genetic components to move toward a highly effective CFTR super exon

328 Cystic Fibrosis Foundation Therapeutics Lab: Omics data repository from cystic fibrosis–relevant in vitro cell models

614 Sensitized high-throughput screening for translational readthrough promoters in the context of the native cystic fibrosis transmembrane conductance regulator R1162X gene

663 Modulation of cystic fibrosis transmembrane conductance regulator intron 22 alternative polyadenylation use may have therapeutic potential for the treatment of certain 3′ cystic fibrosis transmembrane conductance regulator premature termination codon variants

WS16.03 LUNAR-CF: an mRNA replacement approach for cystic fibrosis lung disease

672: Development of a highly sensitive PTC readthrough assay in the context of the full CFTR gene

591: A novel high-throughput screening assay for PTC readthrough modulators relies on the native CFTR gene: Profiling of known compounds

P13.12 Hiv sensitisation health care worker training in vanuatu

584: Delivery of SP-101 restores CFTR function in human CF airway epithelial cultures and drives hCFTRΔR transgene expression in the airways of ferrets

675: Directed differentiation of iPS cells to an airway epithelial tissue model of CF suitable for transepithelial electrophysiology

549: LUNAR-CF: A novel mRNA therapeutic approach to correct the root cause of cystic fibrosis lung disease

638: Demonstration of pharmacologic N1303 K CFTR rescue in heterologous and human tissue-based model systems

Suchergebnisse filtern